Upcoming IPO List

Tatva Chintan Pharma Chem Limited IPO (Tatva Chintan IPO)

Tatva Chintan Pharma Chem Limited, a Gujarat-based speciality chemical company, will hit the market on Friday, July 16, 2021, to raise Rs 500 crores through an Initial Public Offering (IPO) of its units. The company has set the IPO date as well as the price range at which the shares will be offered for sale. Let’s take a peek at the particulars of the Tatva Chintan IPO.

Tatva Chintan IPO Date & Price Band

IPO Open:16 July 2021
IPO Close:20 June 2021
Issue Type:Book Built Issue IPO
Issue Size:Approx ₹500 Crores
Fresh Issue:Approx ₹225 Crores
Offer for Sale:Approx ₹275 Crores
Face Value:₹10 Per Equity Share
Price Band:₹1073 – ₹1083 Per Equity Share
Listing on:BSE, NSE

Tatva Chintan IPO Market Lot

Minimum Lot Size:Minimum 13 Shares
Minimum Amount:₹14,079
Minimum Lot Size:Maximum 182 Shares
Minimum Amount:₹1,97,106

Tatva Chintan IPO Allotment & Listing

Basis of Allotment:26 July 2021
Refunds:27 July 2021
Credit to Demat Account:28 July 2021
Listing Date:29 July 2021

Financials of Tatva Chintan Pharma Chem Limited IPO

Total Assets (in ₹ millions)3,148.032,489.381,875.08
Total Revenue (in ₹ millions)3,062.922,646.222,068.01
Profit After Tax (in ₹ millions)522.62377.89205.43

About Tatva Chintan Pharma Chem Limited

Tatva Chintan Pharma Chem Limited, established in 1996, is a producer of structural control agents (SDAs), phase transmission catalyst (PTCs), intermediates for pharmaceutical and agrochemical processing and other chemicals. It is one of India’s biggest producers of zeolite SDAs.

The company serves clients from all industries, including automotive, oil, agrochemical, dyes and pigments, paints and lacquers, pharmaceutical and personal care. Its products are sold not only in India but are also exported worldwide to 25+ countries including the USA, Germany, South Africa, China and the United Kingdom. In the financial year 2020, total exports represented 76% of total operating revenue.

Some of the company’s customers are Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited and Hawks Chemical Company, Firmenish Aromatics Prod Pvt. At present, it has two Ankleshwar and Dahej facilities in Gujarat.

Objective of the Issue:

The company plans to use the funds from the IPO for the following purposes:

  • Funding of capital expenditures for the expansion of the manufacturing factory in Dahej.
  • Funding of capital expenditure for upgrading R&D facility in Vadodara.
  • To fulfil general corporate objectives.

Leave a Reply

Your email address will not be published. Required fields are marked *